These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14143468)

  • 21. PLEURAL EFFUSIONS, ASCITES, PERICARDIAL EFFUSIONS AND EDEMA IN HODGKIN'S DISEASE.
    WONG FM; GRACE WJ; ROTTINO A
    Am J Med Sci; 1963 Dec; 246():678-82. PubMed ID: 14085223
    [No Abstract]   [Full Text] [Related]  

  • 22. [CYTODIAGNOSIS OF NEOPLASTIC CELLS IN THE FLUIDS OF CAVITARY EFFUSIONS].
    DE VITA DG
    Rev Bras Cir; 1963 Oct; 46():288-91. PubMed ID: 14114219
    [No Abstract]   [Full Text] [Related]  

  • 23. [HYDRALAZINE SYNDROME IN THE LIGHT OF A CASE].
    ELLING P
    Ugeskr Laeger; 1964 Nov; 126():1520-3. PubMed ID: 14237265
    [No Abstract]   [Full Text] [Related]  

  • 24. MEIGS' SYNDROME: A CASE REPORT.
    THIRKELL D; TAYLOR JH; INGRAM CG
    J Coll Gen Pract; 1963 Aug; 6(3):400-7. PubMed ID: 14044050
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathogenesis and management of refractory malignant ascites].
    Saâda E; Follana P; Peyrade F; Mari V; François E
    Bull Cancer; 2011 Jun; 98(6):679-87. PubMed ID: 21636346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [DETERMINATION OF GLUCOSE IN PLEURAL EFFUSIONS].
    RESCIGNO B; PARRELLA M; D'ALFONSO G
    Arch Tisiol Mal Appar Respir; 1963 Jul; 18():670-83. PubMed ID: 14052835
    [No Abstract]   [Full Text] [Related]  

  • 27. An agent for the palliative treatment of neoplastic effusions. Quinacrine (atabrine) hydrochloride.
    JAMA; 1966 Mar; 195(13):1139. PubMed ID: 4159922
    [No Abstract]   [Full Text] [Related]  

  • 28. Malignant effusions.
    Malden LT; Tattersall MH
    Q J Med; 1986 Mar; 58(227):221-39. PubMed ID: 3526384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intracavitary microspheres incorporating cisplatinum in the treatment of malignant effusions--clinical trials].
    Hagiwara A; Takahashi T; Yamaguchi T; Taniguchi H; Iwamoto A; Yoneyama C; Ito M; Sasabe T; Lee M; Wada R
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1575-8. PubMed ID: 2389951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-dose quinacrine (atabrine) and thoracostomy in the control of pleural effusions in patients with neoplastic diseases.
    Borja ER; Pugh RP
    Cancer; 1973 Apr; 31(4):899-902. PubMed ID: 4706055
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
    Zennaro L; Vanzani P; Nicolè L; Cappellesso R; Fassina A
    Cancer Cytopathol; 2017 May; 125(5):341-348. PubMed ID: 28140518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EVALUATION OF PLEURAL AND PERITONEAL EFFUSION CYTOLOGIES.
    OWEN DM; GOETZ CG
    J Miss State Med Assoc; 1965 May; 6(5):174-6. PubMed ID: 14329512
    [No Abstract]   [Full Text] [Related]  

  • 33. The treatment of resistant malignant ascites by insertion of a peritoneo-atrial Holter valve.
    Pollock AV
    Br J Surg; 1975 Feb; 62(2):104-7. PubMed ID: 1115870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recognition of tumorous and non-tumorous cells in cytological studies of serous fluids].
    Kurbatova TI
    Vopr Onkol; 1968; 14(11):29-36. PubMed ID: 5729483
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulation of 99mTc methylene diphosphonate in malignant pleural and ascitic effusion.
    Kida T; Hujita Y; Sasaki M; Inoue J
    Oncology; 1984; 41(6):427-30. PubMed ID: 6239125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RADIOACTIVE COLLOID TREATMENT OF MALIGNANT EFFUSIONS.
    SKLAROFF DM
    Pa Med J; 1965 Jan; 68():41-3. PubMed ID: 14240163
    [No Abstract]   [Full Text] [Related]  

  • 40. Intracavitary administration of radioactive isotopes in the control of effusions due to cancer. Results in 267 patients.
    Ariel IM; Oropeza R; Pack GT
    Cancer; 1966 Aug; 19(8):1096-102. PubMed ID: 5912325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.